Device Trial Radar · NCT05323448
Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.
Last checked: Nov 20, 2026Latest source record: Apr 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
91
Actual
Start
Oct 25, 2022
Primary completion
Mar 9, 2025
Study completion Jul 1, 2025
Sponsor
- Lead sponsor
- Polyclinique Bordeaux Nord AquitaineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Bard Ltd
- First posted
- Apr 12, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to assess the efficacy of the ARISTA AH for restoring hemostasis following a long segment posterior spinal fusion.
Conditions
- Hemostatics
- Hemostasis
- Spinal Deformity
- Spinal Fusion
Interventions
Control GroupDevice
During the surgical procedure, hemostasis will be achieved using the standard of care (electrocautery, pressure, ligature or any hemostatic agent).
ARISTADevice
During the surgical procedure, hemostasis will be achieved using the standard of care (electrocautery, pressure, ligature or any hemostatic agent). Before surgical wound closure, the corresponding amount of ARISTA-AH will be applied to completely cover the bleeding site : * 5g for 5 to 8 instrumented vertebra * 10g fo 9 or more instrumented vertebra
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blood loss within the first 24 hours after posterior spinal fusionTime frame: 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.